Exicure (XCUR) Intangibles (2025 - 2026)
Exicure (XCUR) reported Intangibles of $3.8 million for Q1 2026, little changed on a YoY basis from $3.8 million in Q1 2025, and little changed quarter-over-quarter from $3.8 million in Q4 2025.
Exicure (XCUR) Intangibles (2025 - 2026) Analysis & Trends
Exicure has reported Intangibles for 2 years, with the latest figure at $3.8 million in Q1 2026.
- For the quarter ending Q1 2026, Intangibles changed 0.0% year-over-year to $3.8 million; the trailing twelve-month figure through Mar 2026 stood at $3.8 million (changed 0.0% YoY), and the FY2025 full-year result was $3.8 million, changed N/A from the prior year.
- Intangibles for Q1 2026 stood at $3.8 million, roughly flat from $3.8 million in the prior quarter.
- The five-year high for Intangibles was $3.8 million in Q1 2025, with the low at $3.8 million in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - | - |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - | 4.41 Mn |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn | - |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - | 30.30 Mn |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - | - |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn | 418.50 Mn |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - | 7.73 Mn |
| 10 | Exicure | 19.38 Mn | 16.77 Mn | - | 3.78 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3.78 Mn |
| Dec 31, 2025 | 3.78 Mn |
| Sep 30, 2025 | 3.78 Mn |
| Jun 30, 2025 | 3.78 Mn |
| Mar 31, 2025 | 3.78 Mn |